Published 2010
| Version v1.0.0
Journal Article
Open
Topiramate and Cognitive Function in Migraine
Creators
Abstract
Researchers at the Johnson & Johnson Pharmaceutical Research & Development, New Jersey and Belgium, and University of California, Los Angeles, CA used the Cambridge Neuropsychological Test Automated Battery (CANTAB) and cognitive adverse events to evaluate neurocognitive effects of topiramate 100 mg/day vs placebo in 70 migraine patients aged 12 through 17 years.Files
PNB-24-23-a.pdf
Files
(1.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:d53419be97e35ea6097b318928f797b0
|
1.2 MB | Preview Download |
Additional details
Identifiers
- Other
- PNB-24-23-a
Dates
- Created
-
2010When the item was originally created.